Literature DB >> 6580502

Long term follow-up of remission patients in adult acute leukemia.

D Gerecke, M Kress, W D Hirschmann.   

Abstract

31 adults suffering from acute leukemia were followed for a period of more than 5 years after achieving complete remission. Maintenance chemotherapy consisted of antimetabolite treatment (mercaptopurine + methotrexate) as well as COAP reinduction every 3 months. Chemotherapy was stopped if the first complete remission lasted for 3 years ("long term remission"). This was the case in 8 out of 31 remission patients (26%). Analysis of hematological parameters at diagnose for long term remission patients revealed that the initial leukocyte count was of prognostic significance.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6580502     DOI: 10.1007/bf01550269

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  15 in total

1.  Factors that influence haematological remission duration in acute lymphocytic leukaemia.

Authors:  J V Simone
Journal:  Br J Haematol       Date:  1976-04       Impact factor: 6.998

2.  The immunotherapy of acute myelogenous leukaemia using intravenous BCG.

Authors:  J A Whittaker; A J Slater
Journal:  Br J Haematol       Date:  1977-09       Impact factor: 6.998

3.  Long chemotherapy-free remissions after single-cycle timed-sequential chemotherapy for acute myelocytic leukemia.

Authors:  W P Vaughan; J E Karp; P J Burke
Journal:  Cancer       Date:  1980-03-01       Impact factor: 6.860

4.  One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation.

Authors:  E D Thomas; C D Buckner; M Banaji; R A Clift; A Fefer; N Flournoy; B W Goodell; R O Hickman; K G Lerner; P E Neiman; G E Sale; J E Sanders; J Singer; M Stevens; R Storb; P L Weiden
Journal:  Blood       Date:  1977-04       Impact factor: 22.113

5.  Intensified remission induction therapy for acute nonlymphocytic leukemia (ANLL). Treatment report on 60 patients.

Authors:  D Urbanitz; T Büchner; D Kamanabroo; W Hiddemann; H Schulte; J van de Loo
Journal:  Blut       Date:  1981-08

6.  High rate of long-term survivals in AML treated by chemotherapy and androgenotherapy: a pilot study.

Authors:  D Hollard; J J Sotto; R Berthier; J Leger; M Michallet
Journal:  Cancer       Date:  1980-04-01       Impact factor: 6.860

7.  Cytosine arabinoside (NSC-63878) therapy for acute leukemia in adults.

Authors:  G P Bodey; E J Freireich; R W Monto; J S Hewlett
Journal:  Cancer Chemother Rep       Date:  1969-02

8.  [Long-term survival of adults with acute leukemia [author's transl)].

Authors:  H C Benöhr; G Reu; K Wilms; H D Waller
Journal:  Blut       Date:  1980-06

9.  Remission induction and remission maintenance in adult acute nonlymphocytic leukemia employing a modified cytostatic (COAP) regimen.

Authors:  D Gerecke; W D Hirschmann; R Voigtmann; R Gross
Journal:  Blut       Date:  1979-07

10.  Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient.

Authors:  R L Powles; J Russell; T A Lister; T Oliver; J M Whitehouse; J Malpas; B Chapuis; D Crowther; P Alexander
Journal:  Br J Cancer       Date:  1977-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.